Table 1.
Data of the 60 patients during enrollment in the phase III trial.
| Variables | Values |
|---|---|
| Total numbers | 60 |
| Male: Female | 52:8 |
| Age (years) | 29.8 ± 7.008 |
| HBV DNA (copies/mL) | 4.9 × 104 (Range; 1.7 × 103–1.0 × 1013) |
| Alanine aminotransferase (IU/L) | 58.8 ± 31.5 |
| Level of fibrosis | F0-F2 |
The values of different parameters are provided as absolute numbers (numbers of patients observed and male; female ratio), mean and standard deviation (age and ALT), or median and range (HBV DNA). The levels of fibrosis were mild.